Fate Therapeutics Inc. (FATE)
1.00
-0.12 (-10.71%)
At close: Mar 03, 2025, 1:26 PM
Fate Therapeutics Balance Sheet Statement
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 | FY16 | FY15 | FY14 | FY13 | FY12 | FY11 |
| Cash & Equivalents | 41.87M | 61.33M | 133.58M | 167.35M | 99.81M | 190.51M | 88.95M | 88.61M | 64.81M | 49.1M | 54.04M | 9.09M | 6.39M |
| Short-Term Investments | 273.31M | 374.89M | 482.33M | 315.57M | 121.61M | 10.49M | 12M | 3.5M | n/a | n/a | n/a | n/a | n/a |
| Long-Term Investments | 980K | 4.94M | 100.66M | 28.73M | 39.44M | 2.19M | 122K | 122K | 122K | n/a | n/a | n/a | n/a |
| Other Long-Term Assets | 15.19M | 132.48M | 116.66M | 32.32M | 12.99M | 526K | 24K | 24K | 24K | 132K | 122K | 122K | 122K |
| Receivables | 1.83M | 38.48M | 8.68M | 5.51M | n/a | 500K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Inventory | n/a | 1.00 | n/a | 1.00 | n/a | 1.00 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Current Assets | 14.54M | 27.37M | 8.83M | 4.39M | 4.66M | 3.69M | 3.29M | 2.42M | 1.69M | 1.53M | 1.23M | 706K | 301K |
| Total Current Assets | 331.54M | 502.07M | 633.41M | 494.32M | 227.09M | 205.2M | 102.6M | 93.32M | 65.65M | 49.87M | 54.65M | 9.79M | 6.69M |
| Property-Plant & Equipment | 158.51M | 66.07M | 70.72M | 67.08M | 22.75M | 5.13M | 2.55M | 1.58M | 2.16M | 1.2M | 810K | 1.16M | 1.04M |
| Goodwill & Intangibles | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Total Long-Term Assets | 174.68M | 203.49M | 288.04M | 128.13M | 75.19M | 7.84M | 2.7M | 1.73M | 2.31M | 1.33M | 932K | 1.28M | 1.16M |
| Total Assets | 506.22M | 705.56M | 921.46M | 622.46M | 302.27M | 213.03M | 105.29M | 95.05M | 67.96M | 51.2M | 55.58M | 11.08M | 7.85M |
| Account Payables | 4.72M | 8.27M | 8.61M | 6.28M | 5.82M | 4.21M | 1.68M | 934K | 996K | 645K | 682K | 1.23M | 1.86M |
| Deferred Revenue | 685K | 42.23M | 21.48M | 21.14M | 2.79M | 7.59M | 2.1M | 2.1M | 2.4M | 2.26M | 2.09M | 63K | 146K |
| Short-Term Debt | 6.18M | 11.26M | 11.15M | 6.71M | 3.38M | 2.44M | n/a | 8.19M | 6.55M | 1.55M | 1.73M | 1.94M | 1.25M |
| Other Current Liabilities | 27.51M | 52.3M | 40.03M | 51.43M | 15.81M | 13.03M | 7.27M | 3.96M | 2.49M | 2.39M | 2.19M | 1.37M | 221K |
| Total Current Liabilities | 39.09M | 114.05M | 81.28M | 85.56M | 27.81M | 27.26M | 11.05M | 15.19M | 13.44M | 4.58M | 4.6M | 4.85M | 3.67M |
| Long-Term Debt | 97.36M | 103.71M | 109.24M | 93.94M | 25.23M | 12.45M | 14.81M | 2.5M | 10.69M | 18.08M | n/a | 1.73M | 3.59M |
| Other Long-Term Liabilities | 1.35M | 3.86M | 24.97M | 12.48M | 702K | 5.35M | 1.52M | 1.38M | 857K | 200K | 135K | 57.32M | 51.27M |
| Total Long-Term Liabilities | 98.71M | 107.57M | 161.33M | 152.45M | 29.71M | 25.3M | 17.05M | 6.71M | 16.48M | 18.28M | 135K | 59.05M | 54.86M |
| Total Liabilities | 137.8M | 221.62M | 242.62M | 238.01M | 57.52M | 52.56M | 28.1M | 21.89M | 29.92M | 22.86M | 4.74M | 63.9M | 58.53M |
| Total Debt | 103.54M | 109.34M | 114.82M | 97.3M | 26.93M | 14.88M | 14.81M | 10.69M | 18.24M | 19.63M | 1.73M | 3.67M | 4.84M |
| Common Stock | 99K | 97K | 96K | 88K | 76K | 65K | 53K | 41K | 29K | 21K | 20K | 1K | 1K |
| Retained Earnings | -1.21B | -1.05B | -769.08M | -556.93M | -383.55M | -285.4M | -218.8M | -175.85M | -142.38M | -112.39M | -86.51M | -65.61M | -51.38M |
| Comprehensive Income | 15K | -1.85M | -762K | 70K | 22K | -2K | -3K | -1K | -3.47M | -2.79M | -2.3M | -1.75M | -1.16M |
| Shareholders Equity | 368.42M | 483.94M | 678.84M | 384.44M | 244.76M | 160.47M | 77.19M | 73.15M | 38.04M | 28.34M | 50.85M | -52.83M | -50.68M |
| Total Investments | 274.29M | 379.84M | 582.99M | 315.57M | 161.05M | 10.49M | 12M | 3.5M | 122K | n/a | n/a | n/a | n/a |